Found: 62
Select item for more details and to access through your institution.
Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 3, p. 679, doi. 10.1007/s00432-015-2065-4
- By:
- Publication type:
- Article
Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 5, p. N.PAG, doi. 10.1016/j.clgc.2024.102186
- By:
- Publication type:
- Article
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25).
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 4, p. N.PAG, doi. 10.1016/j.clgc.2024.102099
- By:
- Publication type:
- Article
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 3, p. N.PAG, doi. 10.1016/j.clgc.2024.102078
- By:
- Publication type:
- Article
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study.
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 3, p. N.PAG, doi. 10.1016/j.clgc.2024.102074
- By:
- Publication type:
- Article
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9).
- Published in:
- Clinical Genitourinary Cancer, 2024, v. 22, n. 2, p. 126, doi. 10.1016/j.clgc.2023.10.001
- By:
- Publication type:
- Article
The prognostic Value of Thyroid Hormone Levels in Immunotherapy-Treated Patients With Metastatic Urothelial Carcinoma.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 5, p. e378, doi. 10.1016/j.clgc.2023.04.006
- By:
- Publication type:
- Article
Estimated Direct Costs of Renal Cancer by Stage of Disease at Diagnosis and Phase of Its Management: A Whole-Disease Model.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 4, p. e252, doi. 10.1016/j.clgc.2023.02.002
- By:
- Publication type:
- Article
Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 5, p. 498.e1, doi. 10.1016/j.clgc.2022.06.006
- By:
- Publication type:
- Article
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 2, p. 155, doi. 10.1016/j.clgc.2021.12.008
- By:
- Publication type:
- Article
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?
- Published in:
- Current Oncology Reports, 2021, v. 23, n. 12, p. 1, doi. 10.1007/s11912-021-01140-9
- By:
- Publication type:
- Article
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 2, p. 1096, doi. 10.3390/ijms24021096
- By:
- Publication type:
- Article
Communication in oncology between healthcare providers, patients, the scientific community, and the media: recommendations from the Italian Association of Medical Oncology (AIOM)
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 9, p. 1, doi. 10.1007/s00520-024-08786-8
- By:
- Publication type:
- Article
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 7, p. 1, doi. 10.1007/s00520-023-07867-4
- By:
- Publication type:
- Article
Patient Reported Outcomes, Paternity, Relationship, and Fertility in Testicular Cancer Survivors: Results from a Prospective Observational Single Institution Trial.
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 3393, doi. 10.2147/PPA.S381812
- By:
- Publication type:
- Article
Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology.
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 353, doi. 10.2147/PPA.S351771
- By:
- Publication type:
- Article
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221079580
- By:
- Publication type:
- Article
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211019642
- By:
- Publication type:
- Article
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211019642
- By:
- Publication type:
- Article
International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study).
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12319-1
- By:
- Publication type:
- Article
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03741-2
- By:
- Publication type:
- Article
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03682-w
- By:
- Publication type:
- Article
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2961, doi. 10.1007/s00262-023-03469-5
- By:
- Publication type:
- Article
Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4353, doi. 10.3390/cancers15174353
- By:
- Publication type:
- Article
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2394, doi. 10.3390/cancers15082394
- By:
- Publication type:
- Article
Simultaneous Care in Oncology: A 7-Year Experience at ESMO Designated Centre at Veneto Institute of Oncology, Italy.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2568, doi. 10.3390/cancers14102568
- By:
- Publication type:
- Article
Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa).
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2345185, doi. 10.1001/jamanetworkopen.2023.45185
- By:
- Publication type:
- Article
What do cancer patients experience of the simultaneous care clinic? Results of a cross‐sectional study on patient care satisfaction.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.7000
- By:
- Publication type:
- Article
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14).
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.787835
- By:
- Publication type:
- Article
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b).
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.682449
- By:
- Publication type:
- Article
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical Parameters.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.626104
- By:
- Publication type:
- Article
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations.
- Published in:
- Clinical & Experimental Metastasis, 2024, v. 41, n. 2, p. 117, doi. 10.1007/s10585-024-10266-6
- By:
- Publication type:
- Article
Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2016, v. 6, p. 1, doi. 10.3389/fonc.2016.00253
- By:
- Publication type:
- Article
Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Trabectedin Drug Holiday and Rechallenge in Soft Tissue Sarcomas: Report of 4 Cases and Literature Review.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00553
- By:
- Publication type:
- Article
Tumour Seeding After a Thoracic Biopsy for Renal Cell Carcinoma: A Case Report and a Review of the Literature.
- Published in:
- Clinical Medicine Insights: Oncology, 2021, p. 1, doi. 10.1177/11795549211022261
- By:
- Publication type:
- Article
Tumour Seeding After a Thoracic Biopsy for Renal Cell Carcinoma: A Case Report and a Review of the Literature.
- Published in:
- Clinical Medicine Insights: Oncology, 2021, v. 15, p. 1, doi. 10.1177/11795549211022261
- By:
- Publication type:
- Article
Renal cell carcinoma: the population, real world, and cost-of-illness.
- Published in:
- BMC Urology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12894-022-01160-y
- By:
- Publication type:
- Article
First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response.
- Published in:
- Familial Cancer, 2015, v. 14, n. 2, p. 309, doi. 10.1007/s10689-014-9771-y
- By:
- Publication type:
- Article
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102444
- By:
- Publication type:
- Article
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).
- Published in:
- Targeted Oncology, 2024, v. 19, n. 4, p. 587, doi. 10.1007/s11523-024-01065-w
- By:
- Publication type:
- Article
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 4, p. 467, doi. 10.1007/s11523-022-00892-z
- By:
- Publication type:
- Article
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 1, p. 61, doi. 10.1007/s11523-021-00861-y
- By:
- Publication type:
- Article
A novel immunotherapy prognostic score for patients with pretreated advanced urinary Tract Carcinoma from the subgroup analysis of the SAUL study: the ITACA Score.
- Published in:
- Minerva Urology & Nephrology, 2023, v. 75, n. 3, p. 308, doi. 10.23736/S2724-6051.22.05135-7
- By:
- Publication type:
- Article
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study.
- Published in:
- Minerva Urology & Nephrology, 2022, v. 74, n. 1, p. 11, doi. 10.23736/S2724-6051.20.04032-1
- By:
- Publication type:
- Article
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
- Published in:
- Oncologist, 2022, v. 27, n. 12, p. e949, doi. 10.1093/oncolo/oyac147
- By:
- Publication type:
- Article
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 740, doi. 10.1002/onco.13842
- By:
- Publication type:
- Article
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease‐19 Pandemic: A Survey of International Expertise Centers.
- Published in:
- Oncologist, 2020, v. 25, n. 10, p. e1509, doi. 10.1634/theoncologist.2020-0420
- By:
- Publication type:
- Article